Home » Topics » Regulatory » EMA

EMA
RSS

Tandemact recommended for approval in E.U.

Oct. 23, 2006

European CHMP issues positive opinion on Diacomit submission

Oct. 23, 2006

Adrovance recommended for approval in E.U.

Oct. 23, 2006

Novo Nordisk withdraws E.U. application to expand repaglinide product labels

Oct. 18, 2006

Withdrawal of E.U. marketing authorization for Fortovase

Aug. 14, 2006

Negative opinion handed down for Valdoxan/Thymanax in Europe

Aug. 3, 2006

Positive opinion handed down in Europe for Ganfort

March 28, 2006

Alcon withdraws European submission for Retaane

March 3, 2006

Alcon withdraws application to extend European approval of Opatanol

Feb. 28, 2006

February meeting of European Committee for Orphan Medicinal Products

Feb. 18, 2005

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 8, 2026.
Hengrui discovers new Nav1.8 blockers
BioWorld Science
Researchers from Jiangsu Hengrui Pharmaceuticals Co. Ltd. and Shanghai Hengrui Pharmaceutical Co. Ltd. have patented new sodium channel protein type 10 subunit α...
Hematopoietic stem cell research points to leukemia’s early roots
BioWorld Science
Hematopoietic stem cell (HSC) research over the past century has shown that leukemia may be driven by an invisible hand of inflammation. The bone marrow and...
News in brief
BioWorld Asia
BioWorld Asia briefs for April 7, 2026
Infinimmune presents preclinical data on anti-IL-22 antibody for atopic dermatitis
BioWorld Science
Infinimmune Inc. has recently presented results at the annual American Academy of Dermatology conference regarding their anti-IL-22 antibody IFX-101 for the...